IBC Life Sciences

New Online Partnering System Information

All attendees of this conference will receive access to our new online partnering system before, during and after the event.

Log in information will be sent to you via email shortly after you have completed the registration process. After receiving your username, you may log in here

Keynote Presentations

Biotech 2010 Life Science: Adapting for Success

G. Steven Burrill
Chief Executive Officer
Burrill & Company

Industrialization of mAb Production - Implications, Challenges and Opportunities

Dana Andersen, Ph.D.
Senior Director, Process R&D Oceanside, Operations & Engineering
Genentech, Inc.

Featured Presentations

Battling the Biological and Biochemical Challenges to Efficient Upstream/Downstream Process Integration

Robert D. Kiss, Ph.D.
Director, Late Stage Cell Culture,Process R&D
Genentech, Inc.

Improving Bulk Process Transfer at Centocor: The 'Process-Fit-to-Plant' Program

Charles F. Goochee, Ph.D.
Fellow, CMC Strategy, Large Molecule, Portfolio Management and Technical Integration
J&J/Centocor

PLUS! - Upstream and Downstream Process Development Using a QbD Approach - Results from the CMC Biotech Working Group

Victor A. Vinci, Ph.D.
Director, Bioprocess Operations, Bioproduct R&D
Eli Lilly and Company

Amit Banerjee, Ph.D.
Research Fellow, Global Biologics
Pfizer Inc.

Get Up To Date Event Information

Join our priority contact list and receive the latest event news.

Recombinant Protein & Complex Biologic Development & Production will provide you solutions to the unique challenges encountered when developing and producing therapeutics from recombinant proteins and complex biologics. Take advantage of early registration discounts by securing your seat today.

Industry experts will cover the critical aspects of upstream processing and share strategies in downstream processing. Case studies will detail several successful approaches to choosing and engineering expression systems to maximize yields, control quality, and overcome the bottlenecks encountered during recovery and purification. Throughout the event, companies will deliver case studies that highlight solutions to the unique challenges encountered for several specific protein classes, including alternative scaffold proteins and antibody drug conjugates. By attending, you will also explore applications for the latest tools and disruptive technologies and see how they will impact the future of protein therapeutic development and production.

We invite you to join us on March 3-5 for this comprehensive 3-day program that will allow you to:

• Hear applications of systems biology in cell culture
• Utilize proven approaches to overcome unique challenges in manufacturing, characterization and comparability
• Review the latest strategies for manufacturing alternative scaffold proteins
• See the latest approaches to overcome the complexities of antibody drug conjugate development & production
• Learn the impact of disruptive technologies on the future of protein production

Plus, by attending this conference you will access gain to the sessions and materials for IBC's 24th International Antibody Development & Production conference - 2 conferences for the Price of 1!